48,466
edits
Difference between revisions of "Ductal adenocarcinoma of the prostate gland"
Jump to navigation
Jump to search
Ductal adenocarcinoma of the prostate gland (view source)
Revision as of 14:46, 19 February 2019
, 14:46, 19 February 2019fix image
(fix image) |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
| Micro = | | Micro = | ||
| Subtypes = (subtype of [[prostate carcinoma]]) | | Subtypes = (subtype of [[prostate carcinoma]]) | ||
| LMDDx = [[acinar adenocarcinoma of prostate]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]] | | LMDDx = [[acinar adenocarcinoma of prostate]], [[prostatic-type polyp]], [[adenocarcinoma of the urinary bladder]], metastatic [[adenocarcinoma]] | ||
| Stains = | | Stains = | ||
| IHC = chromogranin A +ve, p53 +ve, PSA +ve | | IHC = chromogranin A +ve, p53 +ve, PSA +ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
| Line 16: | Line 16: | ||
| Grossing = [[prostate biopsy]], [[prostate chips]], [[radical prostatectomy]] | | Grossing = [[prostate biopsy]], [[prostate chips]], [[radical prostatectomy]] | ||
| Staging = [[prostate cancer staging]] | | Staging = [[prostate cancer staging]] | ||
| Site = [[prostate gland]] - central zone | | Site = [[prostate gland]] - esp. central zone, see ''[[prostate cancer]]'' | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Line 62: | Line 62: | ||
DDx: | DDx: | ||
*[[Acinar adenocarcinoma of prostate]] - main DDx. | *[[Acinar adenocarcinoma of prostate]] - main DDx. | ||
*[[Prostatic-type polyp]] - benign uncommon pathology, typically present with hematuria. | |||
*[[Adenocarcinoma of the urinary bladder]]. | *[[Adenocarcinoma of the urinary bladder]]. | ||
*[[PIN-like adenocarcinoma]] - does not have papillary architecture. | |||
*Metastatic [[adenocarcinoma]]. | *Metastatic [[adenocarcinoma]]. | ||
| Line 88: | Line 90: | ||
Others:<ref name=pmid20368883>{{Cite journal | last1 = Kumar | first1 = A. | last2 = Mukherjee | first2 = SD. | title = Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. | journal = Can Urol Assoc J | volume = 4 | issue = 2 | pages = E50-4 | month = Apr | year = 2010 | doi = | PMID = 20368883 }}</ref> | Others:<ref name=pmid20368883>{{Cite journal | last1 = Kumar | first1 = A. | last2 = Mukherjee | first2 = SD. | title = Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment. | journal = Can Urol Assoc J | volume = 4 | issue = 2 | pages = E50-4 | month = Apr | year = 2010 | doi = | PMID = 20368883 }}</ref> | ||
*PSA +ve. | *PSA +ve. | ||
==Sign out== | |||
===Comment about small amount of ductal adenocarcinoma=== | |||
<pre> | |||
A small amount of ductal-type adenocarcinoma of the prostate is seen; it represents approximately 5% of the tumour by volume and is of no particular prognostic significance. As the volume of the ductal-type adenocarcinoma is small, the case is classified as acinar adenocarcinoma. | |||
</pre> | |||
==See also== | ==See also== | ||